AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Determination of the Gene Polymorphisms of Tumor Necrosis Factor-Alpha and Interleukin-10 in Coronary Artery Disease Patients in Iraq

Abbas Ali Menshed1( )Hasan R. Khudhur2Luma Hakem Ali3
Ministry of Education, Directorate of Education Muthanna, Iraq
AL-Muthanna University, Iraq
Ministry of Education, Iraq
Show Author Information

Abstract

Coronary artery disease (CAD) is a widespread kind of cardiovascular disease and is a usual reason of heart attacks, including stable and unstable angina pectoris and myocardial infarctions. We designed this study to examine a probable correlation Interleukin-10 (-1082G/A) and tumor necrosis factor-α (G-308A) gene polymorphism and the coronary artery disease in the Iraqi population. The subjects enrolled in this study were categorized into 2 groups: Group one (140 subjects of CAD), and group two (95 healthy controls). There was no significant correlation between A allele and A/A genotype of TNF-α G-308A, and coronary artery disease patients (p-value = 0.715 and p-value = 0.762 respectively), while there was important correlation between G allele and G/G genotype of IL-10 (G-1082A), and coronary artery disease patients (p-value = 0.005 and p-value = 0.039 respectively). This study indicates that IL-10 G-1082A and TNF-α G-308A gene polymorphism may be considered a risk reason for coronary artery disease in Iraqis.

References

[1]

D.P. Jones, J. Patel, Therapeutic approaches targeting inflammation in cardiovascular disorders. Biology, 2018, 7(4): 49.

[2]

F. Hansen, H. Leif, Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. American Heart Journal, 1997, 134: 48-52.

[3]

S. Ramanujam, Study of coronary artery in cadaver hearts: Morphological aspects. International Journal of Medical and Health Research, 2017, 3(2): 206-208.

[4]

R. Ross, Atherosclerosis - an inflammatory disease. New England Journal of Medicine, 1999, 340: 115-126.

[5]

X. Han, W.A. Boisvert, Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost, 2015, 113: 505-512.

[6]

P. Libby, Inflammation in atherosclerosis. Arteriosclerosis Thrombosis Vascular Biolology, 2012, 32: 2045-2051.

[7]

P.J. Little, A. Chait, and A. Bobik, Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Pharmacology and Therapeutics, 2011, 131: 255-268.

[8]

K.B. Koch, Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis, 2001, 159: 137-144.

[9]

W. Kaluza, S. Grossmann, R. Hug, et al., Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α 238A promoter polymorphism. Journal of Investigative Dermatology, 2000, 114(6): 1180-1183.

[10]

R.B. Singh, S.A. Mengi, A.S. Arneja, et al., Pathogenesis of atherosclerosis: A multifactorial process. Experimental Clinical Cardiology, 2002, 7(1): 40-53.

[11]

J. Bayley, C. Verweij, et al., Is there a future for TNF promoter polymorphisms? Genes and Immunity Journal, 2004, 5: 315-329.

[12]

N. Kevin, G. Daniel, IL-10: The Master Regulator of Immunity to Infection. The Journal of Immunology, 2008, 180: 5771-5777.

[13]

J.M. Fragoso, M. Vallejo, E. Alvarez-Leon, et al., Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients. Cytokine, 2011, 55: 29-33.

[14]

Z. Mallat, S. Besnard, Protective Role of Interleukin-10 in Atherosclerosis. Circulation Research, 1999, 85: 17-24.

[15]

S.M. Herrmann, V. Nicaud, C. Mallet, et al., Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease. European Journal of Clinical Investigation, 1998, 28(1): 59-66.

[16]

H. Chu, J. Yang, S. Mi, et al., Tumour necrosis factor-alpha G-308A polymorphism and risk of coronary heart disease and myocardial infarction: A case-control study and meta-analysis. Journal of Cardiovascular Disease, 2012, 3(2): 84-90.

[17]

L. Ghazouani, TNF-α-308GNA and IL-6-174GNC polymorphisms in Tunisian patients with coronary artery disease. Clinical Biochemistry, 2010, 43: 1085-1089.

[18]

R. Banerjee, V. Parihar, Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. Journal of Thrombosis and Thrombolysis, 2009, 27: 88-94.

[19]

N. Somayyeh, M. Zahra, A. Soheil, et al., Evaluation of relationship between single-nucleotide polymorphism in TNF-gene promoter and susceptibility to atherosclerosis in Fatemeh Zahra Hospital. Research in Molecular Medicine (RMM), 2018, 6(1): 41-53.

[20]

J. Vendrell, C. Gutierrez, A. Zamora, et al., A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis, 2003, 167: 257-264.

[21]

C. Szalai, J. Duba, J. Kramer, et al., Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha complement MHC region with coronary artery disease. Journal of Medical Genetics, 2002, 39(1): 46-51.

[22]

S. Hussain, TNF-alpha-308G>A polymorphism and the risk of familial CAD in a Pakistani population. Human Immunology, 2015, 76: 13-18.

[23]

M.S. Afzal, Influence of IL-10 polymorphism on the development of coronary artery disease in Pakistan. Asian Biomedicine, 2012, 6: 159-165.

[24]

M. Zahra, S.B. Aref, J. Eisa, et al., Association assessment of Interleukine-10 gene polymorphism and its expression status with susceptibility to coronary artery disease in Iran. The Egyptian Journal of Medical Human Genetics, 2018, 19: 31-35.

[25]

M.J. Bown, G.M. Lloyd, R.M. Sandford, et al., The interleukin-10- 1082 'A' allele and abdominal aortic aneurysms. Journal of Vascular Surgery, 2007, 46: 687.

[26]

J. Chen, Z.Q. Sun, J.H. Xia, et al., Relationship between polymorphism of IL-10-1082 gene and coronary atherosclerotic heart diseases. Acta Medicinae Universitatis Science Technologiae Huazhong, 2007, 36: 614-616.

[27]

S. Ben-Hadj-Khalifa, L. Ghazouani, N. Abboud, et al., Functional interleukin-10 promoter variants in coronary artery disease patients in Tunisia. European Cytokine Network, 2010, 21: 136-141.

[28]

E. Karaca, M. Kayıkçıoğlu, H. Onay, et al., The effect of interleukin-10 gene promoter polymorphisms on early-onset coronary artery disease. Anadolu Kardiyoloji Dergisi, 2011, 11: 285-289.

[29]

A. Manginas, A. Tsiavou, A. Chaidaroglou, et al., Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coronary Artery Disease, 2008, 19: 575-582.

Nano Biomedicine and Engineering
Pages 178-183
Cite this article:
Menshed AA, Khudhur HR, Ali LH. Determination of the Gene Polymorphisms of Tumor Necrosis Factor-Alpha and Interleukin-10 in Coronary Artery Disease Patients in Iraq. Nano Biomedicine and Engineering, 2020, 12(2): 178-183. https://doi.org/10.5101/nbe.v12i2.p178-183

557

Views

36

Downloads

1

Crossref

1

Scopus

Altmetrics

Received: 17 April 2020
Accepted: 14 May 2020
Published: 28 June 2020
© Abbas Ali Menshed, Hasan R. Khudhur, and Luma Hakem Ali.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return